The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol.

Terpstra, L C; Altenburg, J; Bronsveld, I; Doodeman, H J; Rozemeijer, W; Heijerman, H G M; Boersma, W G

Terpstra, L C; Altenburg, J; Bronsveld, I; Doodeman, H J; Rozemeijer, W; Heijerman, H G M; Boersma, W G.

Afiliación

Terpstra LC; Department of Pulmonary Diseases, Northwest Clinics, Alkmaar, the Netherlands.
Altenburg J; Department of Pulmonary Diseases, Amsterdam University Medical Centres, Amsterdam, the Netherlands.
Bronsveld I; Department of Pulmonary Diseases, University Medical Center Utrecht and Utrecht University, the Netherlands.
Doodeman HJ; Department of Northwest Academy, Northwest Clinics, Alkmaar, the Netherlands.
Rozemeijer W; Department of Medical Microbiology, Northwest Clinics, Alkmaar, the Netherlands.
Heijerman HGM; Department of Pulmonary Diseases, University Medical Center Utrecht and Utrecht University, the Netherlands.
Boersma WG; Department of Pulmonary Diseases, Northwest Clinics, Alkmaar, the Netherlands.

Contemp Clin Trials Commun ; 30: 101045, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36531900

Palabras clave

Bronchiectasis; Exacerbations; Tobramycin inhalation solution

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: Contemp Clin Trials Commun Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google